Latest filing published 10 Jan 2024 for Fate Therapeutics INC, €57k.
Filing timeline
BuySaleInsider track record
J. Scott Wolchko: trading record in brief
J. Scott Wolchko, listed as chief executive, appears in our data through filings on Fate Therapeutics Inc shares, published by SEC (Form 4). Over a trading history stretching from 31 March 2014 to 9 January 2024, the count stands at 136 filings.
No open-market purchase appears, only 83 sales worth €41.8M. Besides market trades, the filings include 7 share grants and 45 option exercises. Since January 2024: no purchases and 1 sale on the market.
The newest entry dates from 10 January 2024: an open-market sale of €57k, in Fate Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to J. Scott Wolchko
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,391 shares@ US$4.373.0% of flowCommon StockSEC:0000950170-24-003648:0
- 45,907 shares@ US$5.2411.8% of flowCommon StockSEC:0001209191-23-002979:0
- 10,829 shares@ US$32.543.5% of flowCommon StockSEC:0001209191-22-043143:1
- 19,171 shares@ US$33.076.4% of flowCommon StockSEC:0001209191-22-043143:2
- 6,246 shares@ US$2.700.2% of flowCommon StockSEC:0001209191-22-043143:3
- 2,923 shares@ US$31.330.9% of flowCommon StockSEC:0001209191-22-043143:4
- 2,703 shares@ US$32.610.9% of flowCommon StockSEC:0001209191-22-043143:5
- 620 shares@ US$33.280.2% of flowCommon StockSEC:0001209191-22-043143:6
- 30,000 shares@ US$2.704.2% of flowCommon StockSEC:0001209191-22-043143:0
- 22,715 shares@ US$34.577.4% of flowCommon StockSEC:0001209191-22-025515:1
- 4,062 shares@ US$35.731.4% of flowCommon StockSEC:0001209191-22-025515:2
- 2,220 shares@ US$36.700.8% of flowCommon StockSEC:0001209191-22-025515:3
- 1,003 shares@ US$37.900.4% of flowCommon StockSEC:0001209191-22-025515:4
- 10,000 shares@ US$2.700.3% of flowCommon StockSEC:0001209191-22-025515:5
- 9,162 shares@ US$34.543.0% of flowCommon StockSEC:0001209191-22-025515:6
- 838 shares@ US$35.150.3% of flowCommon StockSEC:0001209191-22-025515:7
- 30,000 shares@ US$2.703.9% of flowCommon StockSEC:0001209191-22-025515:0
- 30,000 shares@ US$2.703.8% of flowCommon StockSEC:0000899243-22-004871:0
- 30,000 shares@ US$40.2110.9% of flowCommon StockSEC:0001209191-22-004606:1
- 10,000 shares@ US$2.700.2% of flowCommon StockSEC:0001209191-22-004606:2
- 10,000 shares@ US$38.023.4% of flowCommon StockSEC:0001209191-22-004606:3
- 30,000 shares@ US$2.733.8% of flowCommon StockSEC:0001209191-22-004606:0
- 4,519 shares@ US$49.07Common StockSEC:0001209191-22-003174:1
- 10,047 shares@ US$48.5022.7% of flowCommon StockSEC:0001209191-22-003174:0
- 20,894 shares@ US$47.17Common StockSEC:0001209191-22-003054:1
25 of 136 declarations
